[English] 日本語

- PDB-2ki6: The FGF1-S100A13-C2A hetero-hexameric complex structure: A compon... -
+
Open data
-
Basic information
Entry | Database: PDB / ID: 2ki6 | ||||||
---|---|---|---|---|---|---|---|
Title | The FGF1-S100A13-C2A hetero-hexameric complex structure: A component in the non-classical pathway for FGF1 secretion | ||||||
![]() |
| ||||||
![]() | PROTEIN TRANSPORT / FGF1-S100A13-C2A hetero-hexameric complex / FGF1 / S100A13 / C2A / Calcium / Cell junction / Cytoplasmic vesicle / Glycoprotein / Lipoprotein / Membrane / Metal-binding / Palmitate / Phosphoprotein / Synapse / Transmembrane / Acetylation / Alternative splicing / Angiogenesis / Developmental protein / Differentiation / Growth factor / Heparin-binding / Mitogen / Polymorphism | ||||||
Function / homology | ![]() clathrin-sculpted acetylcholine transport vesicle membrane / Toxicity of botulinum toxin type G (botG) / clathrin-sculpted glutamate transport vesicle membrane / synchronous neurotransmitter secretion / fast, calcium ion-dependent exocytosis of neurotransmitter / positive regulation of calcium ion-dependent exocytosis of neurotransmitter / syntaxin-3 binding / regulation of regulated secretory pathway / spontaneous neurotransmitter secretion / Toxicity of botulinum toxin type B (botB) ...clathrin-sculpted acetylcholine transport vesicle membrane / Toxicity of botulinum toxin type G (botG) / clathrin-sculpted glutamate transport vesicle membrane / synchronous neurotransmitter secretion / fast, calcium ion-dependent exocytosis of neurotransmitter / positive regulation of calcium ion-dependent exocytosis of neurotransmitter / syntaxin-3 binding / regulation of regulated secretory pathway / spontaneous neurotransmitter secretion / Toxicity of botulinum toxin type B (botB) / clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane / calcium-dependent activation of synaptic vesicle fusion / chromaffin granule membrane / dense core granule / GABA synthesis, release, reuptake and degradation / Acetylcholine Neurotransmitter Release Cycle / mesonephric epithelium development / branch elongation involved in ureteric bud branching / clathrin-sculpted monoamine transport vesicle membrane / positive regulation of interleukin-1 alpha production / regulation of endothelial tube morphogenesis / regulation of calcium ion-dependent exocytosis / calcium ion sensor activity / Serotonin Neurotransmitter Release Cycle / FGFR3b ligand binding and activation / vesicle docking / regulation of endothelial cell chemotaxis to fibroblast growth factor / exocytic vesicle / regulation of exocytosis / RAGE receptor binding / Dopamine Neurotransmitter Release Cycle / Norepinephrine Neurotransmitter Release Cycle / vesicle organization / Signaling by activated point mutants of FGFR3 / FGFR3c ligand binding and activation / Phospholipase C-mediated cascade; FGFR3 / protein heterooligomerization / vesicle fusion / positive regulation of dopamine secretion / FGFR2b ligand binding and activation / fibroblast growth factor receptor binding / Glutamate Neurotransmitter Release Cycle / FGFR2c ligand binding and activation / Activated point mutants of FGFR2 / FGFR4 ligand binding and activation / Phospholipase C-mediated cascade; FGFR2 / FGFR1b ligand binding and activation / Phospholipase C-mediated cascade; FGFR4 / positive regulation of dendrite extension / Signaling by activated point mutants of FGFR1 / FGFR1c ligand binding and activation / organ induction / Downstream signaling of activated FGFR1 / Phospholipase C-mediated cascade: FGFR1 / neurotransmitter secretion / calcium-dependent phospholipid binding / neuron projection terminus / membraneless organelle assembly / S100 protein binding / positive regulation of hepatocyte proliferation / syntaxin-1 binding / Neurexins and neuroligins / clathrin binding / low-density lipoprotein particle receptor binding / Signaling by FGFR2 IIIa TM / PI-3K cascade:FGFR3 / mast cell degranulation / regulation of synaptic vesicle exocytosis / phosphatidylserine binding / PI-3K cascade:FGFR2 / PI-3K cascade:FGFR4 / PI-3K cascade:FGFR1 / positive regulation of sprouting angiogenesis / fibroblast growth factor binding / positive regulation of intracellular signal transduction / presynaptic active zone / positive regulation of cell division / postsynaptic cytosol / excitatory synapse / PI3K Cascade / anatomical structure morphogenesis / fibroblast growth factor receptor signaling pathway / detection of calcium ion / positive regulation of synaptic transmission / SHC-mediated cascade:FGFR3 / presynaptic cytosol / SHC-mediated cascade:FGFR2 / SHC-mediated cascade:FGFR4 / SHC-mediated cascade:FGFR1 / regulation of synaptic transmission, glutamatergic / activation of protein kinase B activity / FRS-mediated FGFR3 signaling / vesicle-mediated transport / FRS-mediated FGFR2 signaling / FRS-mediated FGFR4 signaling / Signaling by FGFR3 in disease / FRS-mediated FGFR1 signaling / neurogenesis / Signaling by FGFR2 in disease / phosphatidylinositol-4,5-bisphosphate binding Similarity search - Function | ||||||
Biological species | ![]() | ||||||
Method | SOLUTION NMR / simulated annealing | ||||||
Model details | fewest violations, model 1 | ||||||
![]() | Krishna, S.M. / Rani, S.G. / Yu, C. | ||||||
![]() | ![]() Title: The heterohexameric complex structure, a component in the non-classical pathway for fibroblast growth factor 1 (FGF1) secretion. Authors: Mohan, S.K. / Rani, S.G. / Yu, C. | ||||||
History |
|
-
Structure visualization
Structure viewer | Molecule: ![]() ![]() |
---|
-
Downloads & links
-
Download
PDBx/mmCIF format | ![]() | 4.2 MB | Display | ![]() |
---|---|---|---|---|
PDB format | ![]() | 3.6 MB | Display | ![]() |
PDBx/mmJSON format | ![]() | Tree view | ![]() | |
Others | ![]() |
-Validation report
Arichive directory | ![]() ![]() | HTTPS FTP |
---|
-Related structure data
-
Links
-
Assembly
Deposited unit | ![]()
| |||||||||
---|---|---|---|---|---|---|---|---|---|---|
1 |
| |||||||||
NMR ensembles |
|
-
Components
#1: Protein | Mass: 14783.882 Da / Num. of mol.: 2 / Fragment: C2A domain Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() ![]() #2: Protein | Mass: 15118.044 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() ![]() #3: Protein | | Mass: 11488.180 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() ![]() #4: Protein | | Mass: 11489.187 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() ![]() Has protein modification | N | Sequence details | THE CHAIN C AND D ARE S100A13 MONOMERS; BUT IN CHAIN C AND D THE 94, 97 AND 98 RESIDUES ARE ...THE CHAIN C AND D ARE S100A13 MONOMERS; BUT IN CHAIN C AND D THE 94, 97 AND 98 RESIDUES ARE DIFFERENT ISOMERS (DLY OR LYS). | |
---|
-Experimental details
-Experiment
Experiment | Method: SOLUTION NMR Details: The FGF1-S100A13-C2A hetero-hexameric complex structure | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NMR experiment |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NMR details | Text: C2A(15N&13C labeled) mixed with unlabeled FGF1-S100A13 complex buffer condition (25mM PBD, 100mM NaCl and 2mM CaCl2) |
-
Sample preparation
Details | Contents: 1.0mM [U-100% 13C; U-100% 15N] C2A domain of Syt1-1, 1.0mM FGF1-2, 1.0mM S100A13-3, S100A13-4, 25mM sodium phosphate-5, 100mM sodium chloride-6, 90% H2O/10% D2O Solvent system: 90% H2O/10% D2O | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample |
| ||||||||||||||||||||||||||||
Sample conditions | Ionic strength: 0.1 / pH: 6 / Pressure: ambient / Temperature: 298 K |
-NMR measurement
NMR spectrometer | Type: Bruker Avance / Manufacturer: Bruker / Model: AVANCE / Field strength: 800 MHz |
---|
-
Processing
NMR software |
| ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Refinement | Method: simulated annealing / Software ordinal: 1 / Details: CNS | ||||||||||||||||||||||||||||||||||||
NMR representative | Selection criteria: fewest violations | ||||||||||||||||||||||||||||||||||||
NMR ensemble | Conformer selection criteria: structures with the least restraint violations Conformers calculated total number: 2000 / Conformers submitted total number: 18 / Representative conformer: 1 |